Treatment of Acute Ischemic STroke With Edaravone Dexborneol II (TASTE-2)

Clinical trial NCT05249920 · COMPLETED

Trial details

NCT number: NCT05249920
Sponsor: Beijing Tiantan Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Ischemic Stroke Mechanical Thrombectomy Edaravone Dexborneol Phase III

Start date: 2022-03-18
Primary completion: 2023-02-17
Enrollment: 1362

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.